RSS

Certara

Here, we have a chat with Billy Amzal, PhD, X-Eng, MSc, MPA, who has been appointed as Certara’s senior vice president, decision and real-world data analytics. Read more

Opinion

Certara has celebrated an important milestone for its public health drug development and treatment consulting portfolio after it had successfully supported the team that gained FDA approval for moxidectin. Read more

News

A consortium has been launched by Certara for the development of a quantitative systems pharmacology immune-oncology simulator to test combination cancer therapies and different dose regimens and biomarkers in computer-generated, virtual patients Read more

News

Certara, model-informed drug development & regulatory science company, has acquired a data visualisation SaaS company, BaseCase Management, strengthening its visualisation & communications capabilities across its data science decision-support chain Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Decision support technology and consulting organisation, Certara, has revealed that the US FDA has renewed and expanded its use of the company’s PBPK Simcyp population-based simulator and its paediatric and cardiac safety simulators. Read more

Technology

Here, we talk to the newest member of Certara’s Simcyp Scientific Advisory Board (SAB), Professor Jennifer B. Dressman, PhD. Read more

Opinion

Arsenal Capital Partners has announced it is selling its portfolio company, Certara, to EQT VII Fund for $850 million, although, as a part of the deal, it will retain a minority ownership stake. Read more

News